glucagon has been researched along with Adenoma, Bile Duct in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altarac, S; Bedford, HM; Demetris, AJ; Gollin, SM; Herberman, RB; Iwatsuki, S; Shimizu, Y; Storto, PD; Whiteside, TL | 1 |
1 other study(ies) available for glucagon and Adenoma, Bile Duct
| Article | Year |
|---|---|
Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells.
Topics: Adenocarcinoma; Adenoma, Bile Duct; Animals; Antigens, Neoplasm; Cell Adhesion Molecules; Cell Division; Dexamethasone; Epidermal Growth Factor; Female; Glucagon; Histocompatibility Antigens Class I; Humans; Insulin; Insulin-Like Growth Factor I; Intercellular Adhesion Molecule-1; Karyotyping; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Neoplasm Transplantation; Transplantation, Heterologous; Tumor Cells, Cultured | 1992 |